Cargando…

Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein consistently expressed in all EBV-associated malignancies, and play a critical role in the onset, progression, and/or maintenance of these tumors. Based on the signature changes at amino acid residue 487, EBNA1 is classifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian-ning, Zhang, Na-na, Jiang, Ye, Hui, Da-yang, Wen, Zi-jin, Li, Hai-gang, Ding, Yun-gang, Du, Hong, Shao, Chun-kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506544/
https://www.ncbi.nlm.nih.gov/pubmed/23189182
http://dx.doi.org/10.1371/journal.pone.0050084
_version_ 1782250926557364224
author Chen, Jian-ning
Zhang, Na-na
Jiang, Ye
Hui, Da-yang
Wen, Zi-jin
Li, Hai-gang
Ding, Yun-gang
Du, Hong
Shao, Chun-kui
author_facet Chen, Jian-ning
Zhang, Na-na
Jiang, Ye
Hui, Da-yang
Wen, Zi-jin
Li, Hai-gang
Ding, Yun-gang
Du, Hong
Shao, Chun-kui
author_sort Chen, Jian-ning
collection PubMed
description Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein consistently expressed in all EBV-associated malignancies, and play a critical role in the onset, progression, and/or maintenance of these tumors. Based on the signature changes at amino acid residue 487, EBNA1 is classified into five distinct subtypes: P-ala, P-thr, V-leu, V-val and V-pro. In the present study, the sequence variations of EBNA1 in EBV-associated gastric carcinoma (EBVaGC) and throat washing (TW) samples of healthy EBV carriers in Guangzhou, southern China, where nasopharyngeal carcinoma (NPC) is endemic, were analyzed by PCR and DNA sequencing. V-val subtype was the most predominant (53.6%, 15/28) in EBVaGC, followed by P-ala (42.9%, 12/28) and V-leu (32.1%, 9/28) subtypes. In TWs of healthy EBV carriers, V-val subtype was also predominant (85.7%, 18/21). The sequence variations of EBNA1 in EBVaGC were similar to those in TW of healthy EBV carriers (p>0.05), suggesting that the EBV strains in EBVaGC might originate from the viral strains prevalent within the background population. The predominance of V-val subtype in EBVaGC in Guangzhou was similar to that in EBVaGC in northern China and Japan, but was different from that in EBVaGC in America, suggesting that the variations of EBNA1 in EBVaGC represent geographic-associated polymorphisms rather than tumor-specific mutations. In addition, the EBNA1 variations in EBVaGC in gastric remnant carcinoma were also determined. V-leu subtype was detected in all 4 (100%) cases, although 2 cases occurred as mixed infection with P-ala subtype. This is different from the predominant V-val subtype in EBVaGC in conventional gastric carcinoma, suggesting that V-leu might be a subtype that adapts particularly well to the microenvironment within the gastric stump and enters the remnant gastric mucosa epithelia easily. This, to our best knowledge, is the first investigation of EBNA1 polymorphisms in EBVaGC from endemic area of NPC.
format Online
Article
Text
id pubmed-3506544
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35065442012-11-27 Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China Chen, Jian-ning Zhang, Na-na Jiang, Ye Hui, Da-yang Wen, Zi-jin Li, Hai-gang Ding, Yun-gang Du, Hong Shao, Chun-kui PLoS One Research Article Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein consistently expressed in all EBV-associated malignancies, and play a critical role in the onset, progression, and/or maintenance of these tumors. Based on the signature changes at amino acid residue 487, EBNA1 is classified into five distinct subtypes: P-ala, P-thr, V-leu, V-val and V-pro. In the present study, the sequence variations of EBNA1 in EBV-associated gastric carcinoma (EBVaGC) and throat washing (TW) samples of healthy EBV carriers in Guangzhou, southern China, where nasopharyngeal carcinoma (NPC) is endemic, were analyzed by PCR and DNA sequencing. V-val subtype was the most predominant (53.6%, 15/28) in EBVaGC, followed by P-ala (42.9%, 12/28) and V-leu (32.1%, 9/28) subtypes. In TWs of healthy EBV carriers, V-val subtype was also predominant (85.7%, 18/21). The sequence variations of EBNA1 in EBVaGC were similar to those in TW of healthy EBV carriers (p>0.05), suggesting that the EBV strains in EBVaGC might originate from the viral strains prevalent within the background population. The predominance of V-val subtype in EBVaGC in Guangzhou was similar to that in EBVaGC in northern China and Japan, but was different from that in EBVaGC in America, suggesting that the variations of EBNA1 in EBVaGC represent geographic-associated polymorphisms rather than tumor-specific mutations. In addition, the EBNA1 variations in EBVaGC in gastric remnant carcinoma were also determined. V-leu subtype was detected in all 4 (100%) cases, although 2 cases occurred as mixed infection with P-ala subtype. This is different from the predominant V-val subtype in EBVaGC in conventional gastric carcinoma, suggesting that V-leu might be a subtype that adapts particularly well to the microenvironment within the gastric stump and enters the remnant gastric mucosa epithelia easily. This, to our best knowledge, is the first investigation of EBNA1 polymorphisms in EBVaGC from endemic area of NPC. Public Library of Science 2012-11-26 /pmc/articles/PMC3506544/ /pubmed/23189182 http://dx.doi.org/10.1371/journal.pone.0050084 Text en © 2012 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Jian-ning
Zhang, Na-na
Jiang, Ye
Hui, Da-yang
Wen, Zi-jin
Li, Hai-gang
Ding, Yun-gang
Du, Hong
Shao, Chun-kui
Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title_full Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title_fullStr Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title_full_unstemmed Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title_short Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
title_sort variations of epstein-barr virus nuclear antigen 1 in epstein-barr virus-associated gastric carcinomas from guangzhou, southern china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506544/
https://www.ncbi.nlm.nih.gov/pubmed/23189182
http://dx.doi.org/10.1371/journal.pone.0050084
work_keys_str_mv AT chenjianning variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT zhangnana variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT jiangye variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT huidayang variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT wenzijin variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT lihaigang variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT dingyungang variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT duhong variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina
AT shaochunkui variationsofepsteinbarrvirusnuclearantigen1inepsteinbarrvirusassociatedgastriccarcinomasfromguangzhousouthernchina